ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

Leena MenghaneySubscribe to Leena Menghaney

'Drop the Case'

Evergreening and the issues this practice of abusive patenting raised were first highlighted in the late 1990s with the HIV epidemic, when medicines were priced way out of reach. The Supreme Court’s rejection of Novartis’s patent has set in place an important safeguard to ensure production of affordable generic medicines from India.
Back to Top